Michelle Lavin

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Nathan T. Connell, Veronica H. Flood, Romina Brignardello‐Petersen et al. · Blood Advances · 2021 · 367 citations · Full text

Medicine, Hematology, Hematopathology +16

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Michelle Lavin, Sonia Águila, Sonja Schneppenheim et al. · Blood · 2017 · 134 citations · Full text

Medicine, Hematology, Physiology +11

Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation

Soracha E. Ward, Gerard F. Curley, Michelle Lavin et al. · British Journal of Haematology · 2020 · 119 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +16

Significant gynecological bleeding in women with low von Willebrand factor levels

Michelle Lavin, Sonia Águila, Niall Dalton et al. · Blood Advances · 2018 · 116 citations · Full text

Medicine, Gynecology, Obstetrics +14

ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19

Soracha E. Ward, Helen Fogarty, Ellie Karampini et al. · Journal of Thrombosis and Haemostasis · 2021 · 78 citations · Full text

Medicine, Infectious Diseases, Molecular Biology +13